Jennison Associates LLC Has $860,000 Holdings in Hamilton Lane Incorporated (NASDAQ:HLNE)

Jennison Associates LLC lessened its holdings in Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 95.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,808 shares of the company's stock after selling 123,789 shares during the quarter. Jennison Associates LLC's holdings in Hamilton Lane were worth $860,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. AQR Capital Management LLC boosted its position in Hamilton Lane by 3.7% during the second quarter. AQR Capital Management LLC now owns 8,979 shares of the company's stock valued at $1,110,000 after purchasing an additional 322 shares during the last quarter. Truist Financial Corp boosted its holdings in shares of Hamilton Lane by 6.8% in the 2nd quarter. Truist Financial Corp now owns 12,477 shares of the company's stock valued at $1,542,000 after buying an additional 790 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Hamilton Lane in the second quarter valued at $824,000. Handelsbanken Fonder AB increased its holdings in Hamilton Lane by 75.4% during the third quarter. Handelsbanken Fonder AB now owns 11,400 shares of the company's stock worth $1,920,000 after buying an additional 4,900 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in Hamilton Lane by 32.4% during the third quarter. GAMMA Investing LLC now owns 637 shares of the company's stock worth $107,000 after acquiring an additional 156 shares in the last quarter. Institutional investors and hedge funds own 97.40% of the company's stock.

Hamilton Lane Price Performance

Shares of NASDAQ:HLNE traded down $0.80 during midday trading on Monday, hitting $166.39. The stock had a trading volume of 349,882 shares, compared to its average volume of 424,453. The company's 50-day moving average price is $158.54 and its 200-day moving average price is $163.48. Hamilton Lane Incorporated has a fifty-two week low of $103.42 and a fifty-two week high of $203.72. The company has a quick ratio of 3.37, a current ratio of 4.19 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $9.22 billion, a P/E ratio of 30.70 and a beta of 1.25.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $1.25 EPS for the quarter, beating the consensus estimate of $1.13 by $0.12. The business had revenue of $168.26 million during the quarter, compared to the consensus estimate of $158.86 million. Hamilton Lane had a net margin of 31.12% and a return on equity of 36.69%. The company's revenue was up 34.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.71 earnings per share. As a group, equities research analysts predict that Hamilton Lane Incorporated will post 4.97 EPS for the current fiscal year.

Hamilton Lane Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 4th. Investors of record on Friday, March 14th will be given a dividend of $0.49 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.96 annualized dividend and a dividend yield of 1.18%. Hamilton Lane's dividend payout ratio is currently 36.16%.

Wall Street Analyst Weigh In

HLNE has been the topic of a number of research analyst reports. JPMorgan Chase & Co. upped their target price on shares of Hamilton Lane from $134.00 to $175.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. The Goldman Sachs Group cut Hamilton Lane from a "neutral" rating to a "sell" rating and set a $139.00 price objective for the company. in a research report on Monday, January 6th. Keefe, Bruyette & Woods boosted their target price on Hamilton Lane from $158.00 to $168.00 and gave the stock a "market perform" rating in a report on Wednesday, February 5th. Morgan Stanley increased their price target on Hamilton Lane from $182.00 to $190.00 and gave the company an "equal weight" rating in a research note on Monday, November 11th. Finally, UBS Group lifted their price objective on shares of Hamilton Lane from $150.00 to $185.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 22nd. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $173.14.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.